Odyssey Health (ODYY) EBT (QoQ) (2015 - 2026)
Odyssey Health (ODYY) EBT (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -38.82% |
| Jan 31, 2026 | -49.14% |
| Oct 31, 2025 | -85.72% |
| Jul 31, 2025 | -12.67% |
| Apr 30, 2025 | 13.44% |
| Jan 31, 2025 | 66.06% |
| Oct 31, 2024 | -521.89% |
| Jul 31, 2024 | 132.37% |
| Apr 30, 2024 | 63.47% |
| Jan 31, 2024 | -141.41% |
| Oct 31, 2023 | 33.92% |
| Jul 31, 2023 | 36.58% |
| Apr 30, 2023 | 23.60% |
| Jan 31, 2023 | 21.80% |
| Oct 31, 2022 | -82.70% |
| Jul 31, 2022 | 62.05% |
| Apr 30, 2022 | -41.86% |
| Jan 31, 2022 | -32.71% |
| Oct 31, 2021 | 36.14% |
| Jul 31, 2021 | 79.30% |